DS
AZN icon

DRW Securities’s AstraZeneca AZN Stock Holding History

DRW Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-225,000
Closed -$44.4M – 985
2026
Q1 		$44.4M Buy
225,000
+50,250
+29% +$9.69M 0.62% 24
2025
Q4 		$32.1M Buy
174,750
+112,500
+181% +$19.7M 0.85% 18
2025
Q3 		$9.58M Buy
+62,250
New +$9.42M 0.18% 78
2017
Q3 		– Sell
-27,250
Closed -$1.86M – 65
2017
Q2 		$1.86M Buy
+27,250
New +$1.78M 0.32% 20

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DRW Securities's AZN Position: Q2 2026 in Review

DRW Securities opened a new position in AstraZeneca (AZN) in Q2 2026: 29,772 shares worth $5.65M. The stake represents 0.14% of the portfolio and ranks #110 among its holdings. This is a return to the name: DRW Securities previously reported a position in AZN as recently as Q4 2025.

DRW Securities first reported a position in AZN in Q3 2019 and has held it in 23 quarters since. The position peaked at $12.5M in Q2 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • DRW Securities held 29,772 shares of AstraZeneca worth $5.65M as of Q2 2026.
  • AstraZeneca was a new DRW Securities position in Q2 2026.
  • AstraZeneca made up 0.14% of DRW Securities's portfolio in Q2 2026, its #110 holding.
  • DRW Securities first reported a position in AstraZeneca in Q3 2019 and has held it in 23 quarters since.
  • DRW Securities's AstraZeneca position peaked at $12.5M in Q2 2023.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.